Tõnu Vanakesa
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 2
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Peter Goldstraw (1 shared paper)Vincent Brichard (2 shared papers)Jubrail Dahabreh (4 shared papers)Johan Vansteenkiste (3 shared papers)Jacek Jassem (2 shared papers)M. Zieliński (4 shared papers)Emilio Esteban (3 shared papers)A. Linder (2 shared papers)
In The Last Decade
Tõnu Vanakesa
10 papers receiving 332 citations
Peers
Comparison fields: 5 of 36
- Immunology 220
- Oncology 231
- Pulmonary and Respiratory Medicine 84
- Molecular Biology 87
- Neurology 19
Countries citing papers authored by Tõnu Vanakesa
This map shows the geographic impact of Tõnu Vanakesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tõnu Vanakesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tõnu Vanakesa more than expected).
Fields of papers citing papers by Tõnu Vanakesa
This network shows the impact of papers produced by Tõnu Vanakesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tõnu Vanakesa. The network helps show where Tõnu Vanakesa may publish in the future.
Co-authors
The 25 scholars most cited alongside Tõnu Vanakesa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 245 | |
| 2 | 2014 | 38 | |
| 3 | 1999 | 31 | |
| 4 | 2019 | 7 | |
| 5 | 2018 | 3 | |
| 6 | 2007 | 3 | |
| 7 | MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized | 2009 | 2 |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2011 | 1 |
About Tõnu Vanakesa
Tõnu Vanakesa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Neurology, having authored 10 papers that have together received 332 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Esophageal Cancer Research and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Meningioma and schwannoma management (1 paper). The work is most often cited by research in Immunology (220 citations), Oncology (231 citations), Pulmonary and Respiratory Medicine (84 citations), Molecular Biology (87 citations) and Neurology (19 citations). Tõnu Vanakesa has collaborated with scholars based in Estonia, Japan and Russia. Frequent co-authors include Peter Goldstraw, Vincent Brichard, Jubrail Dahabreh, Johan Vansteenkiste, Jacek Jassem, M. Zieliński, Emilio Esteban, A. Linder, Tom Treasure and Frédéric Lehmann. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, European Journal of Cardio-Thoracic Surgery and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.